The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

A New System Can "See" Hepatitis C Infected Cells

Back to News Homepage

Next

Easing Liver Inflammation: Balancing Omega-3's and Omega-6's

High-Tech Imaging Helps Unravel Hepatitis C's Secrets

February 22, 2010

Print this page

Park Systems’ ultra-modern imaging tool (XE-Bio) gives researchers new insight into the replication process of the Hepatitis C virus. The details revealed by the XE-Bio are likely to inspire new, highly-targeted, Hepatitis C medications.

XE-Bio From Park Systems Brings Promise in Fight Against Hepatitis C

February 16, 2010

(Nanowerk News) The fight against the liver disease hepatitis C has been something of an impasse for years, with more than 150 million people currently infected, and traditional antiviral treatments causing nasty side effects and often falling short of a cure. Park Systems’ XE-Bio helped researchers at Stanford University discover a vulnerable step in the virus’ reproduction process that in lab testing could be effectively targeted with an obsolete antihistamine. XE-Bio successfully imaged and analyzed two of the compounds that most potently inhibit vesicle aggregation revealed their mechanism of action on 4BAH2 function. These results provide new insight into the molecular mechanism of HCV replication platform assembly, and demonstrate the utility of a novel small-molecule anti-HCV strategy.

Continue reading this entire article:
http://www.nanowerk.com/news/newsid=14840.php

No Comments - be the first!
Share
Share

Previous

A New System Can "See" Hepatitis C Infected Cells

Back to News Homepage

Next

Easing Liver Inflammation: Balancing Omega-3's and Omega-6's

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.